Form D · Biotechnology

Guardant Health, Inc.

Redwood City, CA · CIK 0001576280

Offering snapshot reported Aug 9, 2017 · SEC filing

Reported sold
$320M
Offering amount: $320M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 9, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 9, 2017Initial$320,419,351No comparison17SEC filing
Mar 25, 2016Initial$82,843,833No comparison14SEC filing
Mar 30, 2015Initial$55,999,351No comparison21SEC filing
Apr 22, 2014Initial$31,500,000No comparison7SEC filing
Feb 14, 2014Initial$9,216,476No comparison36SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-292432
Series E Preferred Stock and Common Stock issuable upon the conversion of Series E Preferred Stock

Source: Form D, filed Aug 9, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Helmy Eltoukhy Director, Executive
Aaref Hilaly Director
Warren Hogarth Director
Samir Kaul Director
Samir Kaur Director
Amir Ali Talasaz Director, Executive
Michael Wiley Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
505 Penobscot Dr.
Redwood City, CA, 94063